Li Hui Chang

Director of Finance/CFO en FORMOSA OPTICAL TECHNOLOGY CO.,LTD. .

Health Technology

Process Industries

Consumer Services

Perfil

Li Hui Chang is currently working as a Director at Polylite Taiwan Co. Ltd., a Director at Essilor Amera Pte Ltd., and as the Vice President-Finance & Accounting Office at Formosa Optical Technology Co., Ltd.
Mr. Chang completed their undergraduate degree at Fu Jen Catholic University.

Cargos activos de Li Hui Chang

Empresas	Cargo	Inicio
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Director of Finance/CFO	06/11/1995
POLYLITE TAIWAN CO., LTD.	Director/Board Member	01/06/2006
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Director/Board Member	-

Todos los cargos activos de Li Hui Chang

Formación de Li Hui Chang.

Fu Jen Catholic University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Li Hui Chang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Health Technology
POLYLITE TAIWAN CO., LTD.	Process Industries

Empresas privadas	1
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Health Technology